Concurrent Control of Blood Glucose, Body Mass, and Blood Pressure in Patients With Type 2 Diabetes: An Analysis of Data From Electronic Medical Records

Clinical Therapeutics

Volumn 33, Issue 1, 2011, Pages 110-120

  McAdam Marx, Carrie ^a   Bouchard, Jonathan ^b   Aagren, Mark ^b   Conner, Chris ^b   Brixner, Diana I ^a  

^a UNIVERSITY OF UTAH   (United States)

^b NOVO NORDISK INC   (United States)

Author keywords

Dyslipidemia; Glycemic control; HbA1c; Hypertension; Obesity; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; AMBULATORY CARE; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DATA BASE; DIABETIC PATIENT; ELECTRONIC MEDICAL RECORD; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; RISK FACTORS; SELECTION BIAS;

EID: 79952528956     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.01.018     Document Type: Article

References (16)

1. National Diabetes Statistics, 2007 2008, National Diabetes Information Clearing House, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Md.
2. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007 2008, Centers for Disease Control and Prevention, US Dept of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, Ga.
3. Economic Costs of Diabetes in the US in 2007 [published correction appears in Diabetes Care. 2008;31:1271]. Diabetes Care 2008, 31:596-615. American Diabetes Association.
4. Saydah S.H., Fradkin J., Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004, 291:335-342.
5. Standards of medical care in diabetes- 2010 [published correction appears in Diabetes Care. 2010;33:692]. Diabetes Care 2010, 33(Suppl 1):S11-S61. American Diabetes Association.
6. US Dept of Health and Human Services. The Seventh Report of the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure. NIH publication 04-5230.
7. General Electric Clinical Data Services GE Healthcare, Accessed November 12, 2010. https://www2.gehealthcare.com/portal/site/usen/Consulting/.
8. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Centers for Disease Control, Accessed December 7, 2010. http://www.cdc.gov/nchs/icd/icd9cm.htm.
9. Rodbard H.W., Jellinger P.S., Davidson J.A., et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: An algorithm for glycemic control [published correction appears in Endocr Pract. 2009;15:768-770]. Endocr Pract 2009, 15:540-559.
10. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report [published correction appears in JAMA. 2003;290:197]. JAMA 2003, 289:2560-2572. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee.
11. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report 1998, National Institutes of Health, National Institutes of Health, National Heart, Lung, and Blood Institute, Rockville, Md, Report no. 98-4083.
12. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes [published corrections appear in N Engl J Med. 2009;361:1028 and N Engl J Med. 2009;361:1024-1025]. N Engl J Med 2009, 360:129-139. VADT Investigators.
13. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
14. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
15. Gaede P., Vedel P., Larsen N., et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383-393.
16. Electronic Medical Record Use by Office-Based Physicians: United States, 2005 2006, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Md.